Please login to the form below

Not currently logged in
Email:
Password:

Nuplazid

This page shows the latest Nuplazid news and features for those working in and with pharma, biotech and healthcare.

Acadia’s Nuplazid misses the mark in major depressive disorder trial

Acadia’s Nuplazid misses the mark in major depressive disorder trial

Nuplazid was also found to be generally safe to use, with the most common side effects including diarrhoea, dry mouth and headache. ... In this trial, Nuplazid was unable to show a significant improvement compared to placebo on the widely-used Positive

Latest news

More from news
Approximately 3 fully matching, plus 0 partially matching documents found.

Latest appointments

  • Srdjan Stankovic joins Acadia Pharmaceuticals Srdjan Stankovic joins Acadia Pharmaceuticals

    efforts to explore the full potential of Nuplazid to treat patients suffering from additional CNS disorders.” . ... I look forward to leading the team in advancing the promising development programmes with Nuplazid.".

More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wordbird

Wordbird is a healthcare communications agency with creative, compelling copy at its heart....

Latest intelligence

Virtual Engagement At Porterhouse: Reflections on the past few months
A look at how the pitfalls of virtual engagement can be avoided and the key advantages of virtual client and KOL engagement strategies in a now predominantly digital world....
July 2020: diversity and inclusion in clinical trials round-up
COVID-19 has continued to bring diversity and health inequality to the forefront of people’s attention. Our latest round-up covers the July news around these issues, and brings you the latest...
Medical Device Clinical Trials 2020
In July 2020, we attended and exhibited at the Medical Device Clinical Trials 2020 Virtual Experience. We really enjoyed the day and it was great to hear from like-minded people,...

Infographics